Modalis Therapeutics Corp
TSE:4883
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Modalis Therapeutics Corp
TSE:4883
|
JP |
|
Bon-Ton Stores Inc
OTC:BONTQ
|
US |
|
A
|
Arc Funds Ltd
ASX:ARC
|
AU |
|
Thermax Limited
NSE:THERMAX
|
IN |
|
Hansard Global PLC
LSE:HSD
|
IM |
|
Ryman Healthcare Ltd
NZX:RYM
|
NZ |
|
S
|
Sungwoo Hitech Co Ltd
KOSDAQ:015750
|
KR |
|
P
|
Perdoceo Education Corp
XMUN:CE1
|
US |
|
Smith & Nephew PLC
LSE:SN
|
UK |
|
Iress Ltd
ASX:IRE
|
AU |
|
C
|
China Hongqiao Group Ltd
F:H0Q
|
CN |
|
Radiant Opto-Electronics Corp
TWSE:6176
|
TW |
|
Penta Teknoloji Urunleri Dagitim Ticaret AS
IST:PENTA.E
|
TR |
|
O
|
Okta Inc
SWB:0OK
|
US |
Bankruptcy Probability
Modalis Therapeutics Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Modalis Therapeutics Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JP |
|
Modalis Therapeutics Corp
TSE:4883
|
2.7B JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
505.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
197.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
85.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
61B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Modalis Therapeutics Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Modalis Therapeutics Corp has no debt.
You can find a full breakdown on its Balance Sheet.